Lida-KY Announces Board and Independent Director Election at 2026 Annual General Meeting
AI Summary (NQ-processed)
Lida-KY held its 2026 annual general meeting on June 24, completing a full renewal of directors and independent directors due to term expiration. Most incumbent directors were re-elected, ensuring management continuity.
AI Analysis
Frequently Asked Questions
Q: What personnel changes occurred at Lida-KY's 2026 shareholder meeting?
A: Board and independent directors were fully renewed due to term expiration. Corporate directors from Yiyuan and Defu were reappointed; Li Xiaode joined as new independent director.
Q: What is the background of new independent director Li Xiaode?
A: Li Xiaode serves as supervisor at Leading International Biotech, bringing expertise in accounting and auditing.
Q: What was the board turnover rate?
A: Full renewal, but most incumbents were reappointed, ensuring management continuity.
Q: What was the shareholding of outgoing directors?
A: Corporate director Yiyuan holds 36.54 million shares; Defu holds 19.57 million. Individual directors hold none.
Q: When do the new directors take office?
A: The new board members took office on June 24, 2026.